Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis

Trial Identifier: D325BC00001
Sponsor: AstraZeneca
Start Date: July 2021
Primary Completion Date: April 2024
Study Completion Date: April 2024
Condition: Lungs & Respiratory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
AR Florida, AR, B1602DQD
AR San Fernando, AR, B1646EBJ
AR San Miguel de Tucuman, AR, 4000
AU Melbourne, AU, 3004
AU South Brisbane, AU, 4101
CA, ON Ajax, ON, CA, L1S 2J5
CA, ON Burlington, ON, CA, L7N 3V2
CA, ON Windsor, ON, CA, N8X-5A6
CN guangzhou, CN
CN Guangzhou, CN, 510120
CN Shanghai, CN, 200032
CN Zhengzhou, CN, 450000
DE Essen, DE, 45239
DE Frankfurt, DE, 60590
DE Gauting, DE, 82131
DE München, DE, D-80336
DK Aalborg, DK, 9000
DK Hellerup, DK, 2900
DK Hvidovre, DK, 2650
DK Vejle, DK, 7100
ES Barcelona, ES, 08003
ES Madrid, ES, 28040
GB Southampton, GB, SO9 4XY
IN Coimbatore, IN, 641028
IN Hyderabad, IN, 500084
IN New Delhi, IN, 100049
IT Milano, IT, 20122
IT Pisa, IT, 56100
IT Roma, IT, 00168
IT Rozzano, IT, 20089
KR Jeonju, KR, 54907
KR Seoul, KR, 06591
KR Seoul, KR, 04763
KR Seoul, KR, 05030
PH Quezon City, PH, 1100
PL Bydgoszcz, PL, 85-079
PL Ostrowiec Świętokrzyski, PL, 27-400
PL Wrocław, PL, 54-239
RU Penza, RU, 440067
RU Saratov, RU, 410012
RU Ulyanovsk, RU, 432009
US, AL Birmingham, AL, US, 35233
US, CA Newport Beach, CA, US, 92663
US, CA Northridge, CA, US, 91324
US, TX El Paso, TX, US, 79902
VN Ho Chi Minh, VN, 700000
VN Hochiminh, VN, 70000